Disclosures Panels Details Page

Melanoma Panel - Disclosures

Panel Member Mark Albertini MD
Grant/Research Support | Anyxis Immuno-Oncology GmbH | Array BioPharma Inc | Bristol Myers Squibb | Erasca | Merck & Co., Inc.
Date Completed 04/26/2025

Panel Member Christopher Barker MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Sarah Bateni MD, MAS
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Joel Baumgartner MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Shailender Bhatia MD
Grant/Research Support | EMD Serono | Incyte Corporation
Date Completed 03/09/2025

Panel Member Christopher Bichakjian MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Marian Birkeland PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Nicole Blankenhorn
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Genevieve Boland MD, PhD
Equity Interest/Stock Options | Ankyra Therapeutics
Grant/Research Support | Olink Proteomics | Teiko Bio
Date Completed 07/22/2024

Panel Member Sunandana Chandra MD, MS
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member David Chen MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Bartosz Chmielowski MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Dominick DiMaio MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Roxana Dronca MD
Grant/Research Support | BMS
Date Completed 07/30/2024

Panel Member Sara Espinosa PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Martin Fleming MD, FACS
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Anjela Galan MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Kristina Gregory MSN, RN
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Samantha Guild JD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Evelyn Handel PharmD, BCOP, BCPS
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Erin Hesler
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Siwen Hu-Lieskovan MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Douglas Johnson MD, MSCI
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Madeline Joyce BSN, RN, OCN
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Giorgos Karakousis MD
Grant/Research Support | Merck & Co., Inc.
Date Completed 11/27/2024

Panel Member Ann Karosas RPh, BCOP
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Kari Kendra MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Maija Kiuru MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Julie Lange MD, ScM
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Ryan Lanning MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Theodore Logan MD, FACP
Grant/Research Support | Abbott Laboratories | Abraxis Bioscience, Inc. | Acceleron Pharma, Inc. | Amgen Inc. | Argos Therapeutics | AstraZeneca Pharmaceuticals LP | AVEO Pharmaceuticals, Inc. | Biovex | Bristol Myers Squibb | Cerulean | Dynavax | Eisai Inc. | Eli Lilly and Company | EMD Serono | GSK | Iovance pharmaceuticals | MacroGenics | MedImmune Inc. | Merck & Co., Inc. | NiKang | Novartis Pharmaceuticals Corporation | Peloton Therapeutics, Inc. | Pfizer Inc. | Prometheus | Roche Laboratories, Inc. | Synta Pharmaceuticals Corp. | Threshold Pharmaceuticals | Tracon
Date Completed 04/29/2025

Panel Member Miguel Materin MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Christine McLaughlin
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Nicole McMillian MS
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Kelly Nelson MD, FAAD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Aaron Oliver PharmD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Daniel Olson MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Anthony Olszanski MD, RPh
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Svitlana Ostanina PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Patrick Ott MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Donna Powell DHSc, CMD, RT(T)
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Igor Puzanov MD, MSCI, FACP
Equity Interest/Stock Options | IDEAYA
Date Completed 06/10/2024

Panel Member Luke Rothermel MD, MPH
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member April Salama MD
Grant/Research Support | Ascentage | Bristol Myers Squibb | Ideaya | Immunocore | Merck & Co., Inc. | Olatec Therapeutics | Regeneron Pharmactcls | Replimune | SeaGen
Date Completed 08/09/2024

Panel Member Rohit Sharma MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Arun Singh MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Andrew Stacey MD, MS
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Susan Swetter MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Katy Tsai MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Evan Wuthrick MD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.

Panel Member Yan Xing MD, PhD
The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose.